Explore the latest in breast cancer from The JAMA Network, including recent guidelines and advances in screening, genetic testing, and precision treatment.
This cohort study examines the prognostic role of CD8+ T lymphocytes for survival among women with epithelial ovarian cancer.
This Teachable Moment uses the details of a case report to evaluate the risks and benefits of staging imaging in early-stage breast cancer.
This case report describes a patient who developed postirradiation lichen sclerosus et atrophicus.
This analysis of patients with breast cancer insured through the health insurance marketplace assesses their quality of care by examining patterns of radiation therapy.
This cohort study describes surgeons’ approach to surgical margins for invasive breast cancer, changes in postlumpectomy surgery rates, and final surgical treatment following a 2014 consensus statement endorsing a margin of “no ink on tumor.”
This secondary analysis of a randomized clinical trial examines DNA samples and family history of patients with triple-negative breast cancer to determine response to and survival from neoadjuvant treatment.
This cohort study compares the incidence of surgical site infection and noninfectious wound complications after immediate, delayed, and secondary implant and autologous breast reconstruction in patients undergoing mastectomy.
This study describes the oncologic safety of nipple-sparing mastectomy and provides evidence-based data regarding preservation of the nipple-areolar complex during a risk-reducing mastectomy in a population with BRCA mutations.
This population-based survey study assesses the influence of attending surgeons on rates of contralateral prophylactic mastectomy in women with breast cancer.
This noninferiority trial compares 10-year overall survival of women with invasive breast cancer and sentinel lymph node metastases treated with breast-conserving therapy and sentinel lymph node dissection alone vs axillary dissection.
This case-control study compares the surgical site complications associated with oncoplastic breast surgery with intraoperative radiotherapy and oncoplastic breast surgery with whole-breast radiotherapy within 6 months of surgery.
This survey study examines how women in the general US population perceive the benefits and harms of mammography screening.